Filing Details
- Accession Number:
- 0001209191-19-012296
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-21 19:24:00
- Reporting Period:
- 2019-02-19
- Accepted Time:
- 2019-02-21 19:24:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1649167 | Frederic Pla | 301 Penobscot Dr. Redwood City CA 94063 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-02-19 | 1,500 | $31.98 | 41,178 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-02-19 | 1,400 | $27.00 | 42,578 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-02-19 | 2,800 | $27.48 | 45,378 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-02-19 | 6,084 | $82.93 | 39,294 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-19 | 3,616 | $83.55 | 35,678 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-19 | 1,500 | $0.00 | 1,500 | $31.98 |
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-02-19 | 1,400 | $0.00 | 1,400 | $27.00 |
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-02-19 | 2,800 | $0.00 | 2,800 | $27.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
78,667 | 2025-01-01 | No | 4 | M | Direct | |
19,167 | 2026-02-16 | No | 4 | M | Direct | |
46,453 | 2027-01-31 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 22,874 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $82.30 to $83.29.
- Represents weighted average sale price. Actual sale prices ranged from $83.30 to $83.96.
- The option became exercisable as to 25% of the shares on January 1, 2016, and became exercisable as to 1/48th of the shares each full month thereafter.
- The option became exercisable as to 25% of the shares on February 16, 2017, and became exercisable as to 1/48th of the shares each full month thereafter.
- The option became exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter.